IOL Chemicals & Pharmaceuticals Share Price

    NSE
    92.89
    -0.52 (1.08%)
    IOLCP • 04 Jul, 2025 | 11:32 AM
    BUY

    1Y Annualised Return

    10.56%

    3Y Annualised Return

    12.41%

    5Y Annualised Return

    -2.82%

    The current prices are delayed, login or Open Demat Account for live prices.

    IOL Chemicals & Pharmaceuticals Stock Performance

    1W Return-4.44
    1Y Return10.26
    Today's Low92.82
    Prev. Close93.41
    Mkt Cap (Cr.)2,741.84
    1M Return7.65
    3Y Return41.07
    52-Week High107.54
    Open93.41
    PE Ratio27.15
    6M Return9.41
    Today's High94.91
    52-Week Low57.5
    Face Value2

    IOL Chemicals & Pharmaceuticals Company background

    Founded in: 1986
    Managing director: Varinder Gupta
    IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active PharmaceuticalIngredient (API) and specialty chemicals sectors. With substantive manufacturing capacities, the Company benefits from economiesof scale and cost supremacy. Its extensive expertise in both API and specialty chemicals strengthens its business model and opens doors to diversified growth opportunities.Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines. It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride. The Company is a leader in fostering green chemistry through its extensive production of Ethyl Acetate, a sustainable and environmentally friendly solvent. As one of the largest manufacturers globally, the Company plays a vital role in promoting the adoption of ecofriendly practices in various industries such as pharmaceuticals, printing, flexible packaging, adhesives, surface coatings, flavors, paints lamination, and essences.The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene. The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Rallis India, Hindustan Polymide, Gujarat Super Phosphate and Avon Organics Ltd etc.The capacity enhancement project and Multi Product PPIs Plant and other pharmaceutical intermediate products with a CAPEX of Rs 130 crore was completed in 2012. The Company undertook another project of multi product plant for manufacture active pharmaceutical ingredients and upgrading of RD facilities involving a CAPEX of Rs 58.41 crore.G Drugs and Pharmaceuticals Limited (GDPL) was merged with Company, through The Board for Industrial and Financial Reconstruction (BIFR), vide its order dated 15 March 2012, with appointed date of 1 April 2010. The said Merger was made effective on 20 April 2012 and consequently GDPL ceased to exit from that date.During the current year 201617, the Company converted its existing multiple purpose plant into a dedicated ibuprofen manufacturing facility and resulting to its conversion, the ibuprofen manufacturing facility increased from 6200 TPA to 7200 TPA. During year 201718, Unit III to manufacture Fenofi brate, Clopidogrel and Lamotrigine Project was set up which costed Rs 16.48 crore. The company also setup Unit IV for manufacturing Metformin an antidiabetic drug with a capacity of 3000 MT per annum with project cost of Rs 10.02 crore. It enhanced installed capacity of Ibuprofen from 7200 TPA to 10000 TPA by debottlenecking and reengineering the plant in the month of August 2018.During year 2019, the Company has enhanced installed capacity of Metformin from 3,000 TPA to 4,000 TPA with a capex of Rs 2.71 crore it set up Unit V o manufacture Clopidogrel Bisulphate Fenofibrate with a capacity of 180 MT per annum with capex of Rs 19.26 crore it further enhanced existing manufacturing facilities of Ibuprofen from 10,000 TPA to 12,000 TPA and Iso Butyl Benzene from 9,000 TPA to 12,000 TPA in May 2019 with capex of Rs 12.10 crore. During 2020, the Company set up Unit VI, with an installed capacity of 240 MT per annum, which costed Rs 33.83 Crore, to manufacture Pantoprazole and has started its trial production. During 2021, the Company set up an another Unit7 for manufacturing Metformin with an additional capacity of 7,200 MT per annum for project costing Rs 28 cr. It installed new manufacturing facilities Unit8 to manufacture Ibuprofen Derivatives and other Pharma Products during FY 202021. It increased existing manufacturing facilities of Ethyl Acetate from 87,000 MT per annum to 100,000 MT per annum in Chemical segment during 202122.During the year 202223, IOL Foundation was incorporated as wholly owned subsidiary company. The Company set up multi product manufacturing facilities Unit 10 for manufacturing pharma APIs. It identified to manufacture Fenofibrate, Lamotrigine etc in this unit. Further, it also initiated the project for installation of new manufacturing facilities (Unit9) for manufacturing Gabapentin and other Pharma products during the year, which is under implementation.In 202324, Company commenced the production of Acetic Anhydride in the chemical division mainly for captive consumption as well as merchant sale with installed capacity of 25000 MTPA.

    As of 04 Jul, 2025, IOL Chemicals & Pharmaceuticals share price is ₹93.2. The stock opened at ₹93.4 and had closed at ₹93.4 the previous day. During today’s trading session, IOL Chemicals & Pharmaceuticals share price moved between ₹92.82 and ₹94.91, with an average price for the day of ₹93.86. Over the last 52 weeks, the stock has recorded a low of ₹57.50 and a high of ₹107.54. In terms of performance, IOL Chemicals & Pharmaceuticals share price has increased by 9.4% over the past six months and has increased by 10.56% over the last year.

    Read More
    IOL Chemicals & Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹68,56,923 (+5.49%)

    Daily SIP of 25,000 would have become 68,56,923 in 1 year with a gain of 3,56,923 (+5.49%)

    View details of Market Depth

    IOL Chemicals & Pharmaceuticals Fundamental

    Market Cap (in crs)

    2,741.84

    Face Value

    2

    Turnover (in lacs)

    536.24

    Key Metrics

    Qtr Change %
    62.02% Gain from 52W Low
    42.9
    Dividend yield 1yr %
    Below industry Median
    0.9

    IOL Chemicals & Pharmaceuticals Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    IOL Chemicals & Pharmaceuticals Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    527.78 Cr
    523.3 Cr
    525.75 Cr
    502.38 Cr
    503.92 Cr
    IOL Chemicals & Pharmaceuticals Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    2101.62 Cr
    2162.86 Cr
    2242.72 Cr
    2216.06 Cr
    IOL Chemicals & Pharmaceuticals Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    31.42 Cr
    20.53 Cr
    19.15 Cr
    29.97 Cr
    27.62 Cr
    IOL Chemicals & Pharmaceuticals Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    101.07 Cr
    134.43 Cr
    139.14 Cr
    167.67 Cr

    IOL Chemicals & Pharmaceuticals Result Highlights

    • IOL Chemicals & Pharmaceuticals Ltd reported a 3.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 14.2%.

    • Its expenses for the quarter were down by 5.1% QoQ and 6.8% YoY.

    • The net profit increased 34.5% QoQ and decreased 57.4% YoY.

    • The earnings per share (EPS) of IOL Chemicals & Pharmaceuticals Ltd stood at 4.7 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in IOL Chemicals & Pharmaceuticals

    Promoter
    52.6%
    Foreign Institutions
    1.5%
    Public
    45.8%
    Promoter
    52.6%
    Foreign Institutions
    1.5%
    Domestic Institutions
    0.1%
    Public
    45.8%
    Promoter
    48.2%
    Foreign Institutions
    1.6%
    Domestic Institutions
    0.1%
    Public
    50.1%
    Promoter
    48.2%
    Foreign Institutions
    1.4%
    Mutual Funds
    0.1%
    Domestic Institutions
    0.1%
    Public
    50.3%
    Promoter
    48.2%
    Foreign Institutions
    1.4%
    Mutual Funds
    0.1%
    Domestic Institutions
    0.3%
    Public
    50.1%
    Promoter
    48.2%
    Foreign Institutions
    2.2%
    Mutual Funds
    0.1%
    Domestic Institutions
    0.4%
    Public
    49.3%

    IOL Chemicals & Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    92.89
    Current Price
    Bullish Moving Averages
    11
    Bearish Moving Averages
    5
    5Day EMA
    95.00
    10Day EMA
    93.90
    12Day EMA
    93.40
    20Day EMA
    91.30
    26Day EMA
    89.80
    50Day EMA
    84.40
    100Day EMA
    79.70
    200Day EMA
    78.50
    5Day SMA
    96.10
    10Day SMA
    94.00
    20Day SMA
    91.20
    30Day SMA
    90.00
    50Day SMA
    82.10
    100Day SMA
    74.00
    150Day SMA
    75.70
    200Day SMA
    78.00
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    406833 Rs
    764362 Rs
    Week Rs
    734977 Rs
    1657353 Rs
    Month Rs
    705082 Rs
    1495092 Rs
    94.14
    Pivot
    Resistance
    First Resistance
    95.23
    Second Resistance
    97.05
    Third Resistance
    98.14
    Support
    First Support
    92.32
    Second support
    91.23
    Third Support
    89.41
    Relative Strength Index
    57.95
    Money Flow Index
    71.07
    MACD
    3.62
    MACD Signal
    3.64
    Average True Range
    3.81
    Average Directional Index
    32.97
    Rate of Change (21)
    7.94
    Rate of Change (125)
    13.51

    IOL Chemicals & Pharmaceuticals Latest News

    01 JUL 2025 | Tuesday

    IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Credit Rating

    26 JUN 2025 | Thursday

    IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading Window

    13 JUN 2025 | Friday

    IOL Chemicals & Pharmaceuticals Ltd - 524164 - REACH Registration For Acetic Anhydride

    View More

    IOL Chemicals & Pharmaceuticals Share Price FAQs

    IOL Chemicals & Pharmaceuticals share price is ₹92.89 in NSE and ₹92.87 in BSE as on 4/7/2025.

    IOL Chemicals & Pharmaceuticals share price in the past 1-year return was 10.26. The IOL Chemicals & Pharmaceuticals share hit a 1-year low of Rs. 57.5 and a 1-year high of Rs. 107.54.

    The market cap of IOL Chemicals & Pharmaceuticals is Rs. 2741.84 Cr. as of 4/7/2025.

    The PE ratios of IOL Chemicals & Pharmaceuticals is 27.15 as of 4/7/2025.

    The PB ratios of IOL Chemicals & Pharmaceuticals is 1.62 as of 4/7/2025

    The Mutual Fund Shareholding in IOL Chemicals & Pharmaceuticals was 0.02% at the end of 4/7/2025.

    You can easily buy IOL Chemicals & Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of IOL Chemicals & Pharmaceuticals share price is ₹107.54 and ₹57.5 as of 4/7/2025.

    Please be aware that IOL Chemicals & Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.49
    +0.22 (+0.34%)
    139.83
    +0.13 (+0.09%)
    690.15
    -0.25 (-0.04%)
    2,613.00
    +1.80 (+0.07%)
    167.99
    +0.47 (+0.28%)
    392.00
    +1.35 (+0.35%)
    164.40
    -1.51 (-0.91%)
    262.70
    +1.85 (+0.71%)
    430.50
    +4.25 (+1.00%)
    402.60
    +2.70 (+0.68%)
    Top Gainers
    928.70
    +18.55 (+2.04%)
    4,367.20
    +56.60 (+1.31%)
    2,000.10
    +19.40 (+0.98%)
    430.05
    +3.80 (+0.89%)
    262.85
    +2.00 (+0.77%)
    Top Losers
    5,670.00
    -521.00 (-8.42%)
    163.71
    -2.20 (-1.33%)
    5,647.00
    -69.00 (-1.21%)
    1,654.80
    -17.10 (-1.02%)
    1,792.80
    -17.40 (-0.96%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -